Genpact director awarded 6,521 restricted shares

Morken CeCelia reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Morken CeCelia reported acquisition or exercise transactions in this Form 4 filing.

Genpact Ltd director CeCelia Morken received an equity grant in the form of restricted share units (RSUs). The award covers 6,521 common shares granted at no cash cost under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles her to one common share at a future date, subject to continued service. The RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027. Following this grant, she directly holds 64,281 common shares.

Insider Trade Summary

Grant/Award: 6,521 shares

Grant/Award 1 txn

Insider Morken CeCelia

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	6,521	$0.00	$0.00

Holdings After Transaction: Common Shares — 64,281 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Key Figures

RSU award size: 6,521 shares Grant price per share: $0.00 per share Shares held after grant: 64,281 shares +2 more

5 metrics

RSU award size 6,521 shares Restricted share units granted on April 23, 2026

Grant price per share $0.00 per share Equity award with no cash cost to insider

Shares held after grant 64,281 shares Total Genpact common shares directly held post-transaction

RSU vesting date December 31, 2026 Full vesting date subject to continued service

Settlement date December 31, 2027 RSUs to be settled in common shares

Key Terms

restricted share units (RSUs), Genpact Limited 2017 Omnibus Incentive Compensation Plan, unvested, vest, +1 more

5 terms

restricted share units (RSUs) financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

Genpact Limited 2017 Omnibus Incentive Compensation Plan financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

unvested financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

vest financial

"Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

settled in common shares financial

"and will be settled in common shares on December 31, 2027."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Genpact (G) director CeCelia Morken receive in this Form 4 filing?

CeCelia Morken received 6,521 restricted share units (RSUs) of Genpact common shares as an equity grant. The award was made under the 2017 Omnibus Incentive Compensation Plan at no cash cost and increases her direct share-based holdings.

How do the new RSUs for Genpact (G) vest and settle?

The 6,521 RSUs granted to CeCelia Morken will fully vest on December 31, 2026, subject to her continued service. They will then be settled in common shares on December 31, 2027, turning the units into actual Genpact shares at that time.

What does each RSU granted by Genpact (G) represent?

Each restricted share unit (RSU) granted to CeCelia Morken represents the right to receive one Genpact common share at a future date. Delivery of the shares is contingent on the vesting schedule and her continued service through the specified vesting date.

How many Genpact (G) shares does CeCelia Morken hold after this RSU grant?

After the RSU grant reported in the Form 4, CeCelia Morken directly holds 64,281 Genpact common shares. This figure, disclosed in the filing, reflects her ownership position immediately following the award of 6,521 restricted share units.

Under which plan were the new Genpact (G) RSUs granted?

The 6,521 RSUs granted to CeCelia Morken were issued under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. This plan provides for equity-based awards such as RSUs, aligning director and executive compensation with Genpact’s share performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 04:25 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morken CeCelia

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NEW YORK 10175

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	04/23/2026		A		6,521(1)	A	$0	64,281	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for CeCelia Morken	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)